HDAC9 and Alzheimer disease: For hydroxamic acids with high HDAC6-inhibiting activity, we also conducted docking analyses against the crystal structure of HDAC6 (PDB: 5EDU), where the features of the interaction of compounds with the sixth isoform of human HDAC, most commonly associated with Alzheimer’s disease, were revealed.